Aktienanalyse zu Pulsenmore Ltd (PLSM)PLSMPulsenmore Ltd

Pulsenmore Ltd is an Israel-based medical equipment company. The Company engaged in the field of research and development activity, production, marketing and sales worldwide of solutions and technologies that concern portable ultrasound devices for home use by the patient for a remote physical examination or monitoring using telehealth technology. he company has developed and sells two miniaturized ultrasound systems: the first is called PulseNmore ES, for performing home ultrasound tests for pregnant women; and the second is called PulseNmore FC, for performing a self-test of the size of the follicles in women who are in the process in vitro fertilization. Both systems make use of a smart mobile phone and make the test accessible without the need o visit in clinic or hospital, while being able to transfer film for the doctor, the treating medical team or the hotline online. Moreover the COmpany delivers software for its products. It operates in the Healthcare sector.

Pulsenmore Ltd is not a good buy right now due to its extremely low RSI of 17.754, indicating oversold conditions, and a staggering year-to-date change of -72.80%. These factors suggest significant downward momentum and a lack of investor confidence. The forward P/E ratio is also 0, indicating no earnings growth expected in the near term, which is a red flag for long-term investors. The main risk is the negative sentiment surrounding the stock, as it has experienced a 12.59% decline over the last five days, reflecting ongoing volatility and uncertainty.